Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells-Reference-Cited by-同舟云学术

Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells

Published:2019-09 Issue:9 Volume:60 Page:1590-1602
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Kao Li-Pin,Morad Samy A.F.,Davis Traci S.,MacDougall Matthew R.,Kassai Miki,Abdelmageed Noha,Fox Todd E.,Kester Mark,Loughran Thomas P.,Abad Jose' L.,Fabrias Gemma,Tan Su-Fern^ORCID,Feith David J.,Claxton David F.,Spiegel Sarah,Fisher-Wellman Kelsey H.,Cabot Myles C.

Funder

National Institutes of Health

Brody Brothers Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference69 articles.

1. How can one optimize induction therapy in AML?;Luger;Best Pract. Res. Clin. Haematol.,2017

2. Treatment of relapsed/refractory acute myeloid leukaemia in adults;Rashidi;Br. J. Haematol.,2018

3. Toward a better understanding of the complexity of cancer drug resistance;Gottesman;Annu. Rev. Pharmacol. Toxicol.,2016

4. Leukemia and ABC transporters;Fukuda;Adv. Cancer Res.,2015

5. Drug resistance: still a daunting challenge to the successful treatment of AML;Shaffer;Drug Resist. Updat.,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial electron transport chain, ceramide, and coenzyme Q are linked in a pathway that drives insulin resistance in skeletal muscle;eLife;2023-12-27

2. Mitochondrial electron transport chain, ceramide, and coenzyme Q are linked in a pathway that drives insulin resistance in skeletal muscle;eLife;2023-12-27

3. Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia;Cancers;2023-12-15

4. Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy;Scientific Reports;2023-12-09

5. Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia;2023-10-23